Related Experiment Video
Updated: Oct 28, 2025
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
Droplet Microfluidics for Tumor Drug-Related Studies and Programmable Artificial Cells
Pantelitsa Dimitriou1, Jin Li1, Giusy Tornillo2
1Applied Microfluidic Laboratory School of Engineering Cardiff University Cardiff CF24 3AA UK.
Abstract:
Anticancer drug development is a crucial step toward cancer treatment, that requires realistic predictions of malignant tissue development and sophisticated drug delivery. Tumors often acquire drug resistance and drug efficacy, hence cannot be accurately predicted in 2D tumor cell cultures. On the other hand, 3D cultures, including multicellular tumor spheroids (MCTSs), mimic the in vivo cellular arrangement and provide robust platforms for drug testing when grown in hydrogels with characteristics similar to the living body. Microparticles and liposomes are considered smart drug delivery vehicles, are able to target cancerous tissue, and can release entrapped drugs on demand. Microfluidics serve as a high-throughput tool for reproducible, flexible, and automated production of droplet-based microscale constructs, tailored to the desired final application. In this review, it is described how natural hydrogels in combination with droplet microfluidics can generate MCTSs, and the use of microfluidics to produce tumor targeting microparticles and liposomes. One of the highlights of the review documents the use of the bottom-up construction methodologies of synthetic biology for the formation of artificial cellular assemblies, which may additionally incorporate both target cancer cells and prospective drug candidates, as an integrated "droplet incubator" drug assay platform.
Insights
This review explores using microfluidics and natural hydrogels to create 3D tumor models (MCTSs) and targeted drug delivery systems. These advanced platforms improve anticancer drug development and testing by mimicking in vivo conditions.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Drug Delivery Systems
Background:
- Traditional 2D tumor cultures lack the complexity for accurate drug resistance and efficacy prediction.
- 3D multicellular tumor spheroids (MCTSs) in hydrogels better mimic in vivo tumor microenvironments.
- Smart drug delivery vehicles like microparticles and liposomes offer targeted cancer treatment.
Purpose of the Study:
- To review the integration of natural hydrogels and droplet microfluidics for generating MCTSs.
- To discuss microfluidic methods for producing tumor-targeting microparticles and liposomes.
- To highlight synthetic biology approaches for creating integrated drug assay platforms.
Main Methods:
- Utilizing droplet microfluidics for high-throughput production of microscale constructs.
- Employing natural hydrogels to create biocompatible environments for MCTS growth.
- Applying bottom-up synthetic biology for constructing artificial cellular assemblies.
Main Results:
- Demonstrated generation of MCTSs using hydrogels and droplet microfluidics.
- Showcased microfluidic production of targeted microparticles and liposomes.
- Presented integrated "droplet incubator" platforms incorporating cancer cells and drugs.
Conclusions:
- Microfluidics and hydrogels offer a powerful combination for advanced 3D tumor modeling and drug delivery.
- Synthetic biology enables novel "droplet incubator" platforms for integrated drug screening.
- These approaches significantly advance anticancer drug development and personalized medicine.
More Related Videos
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
07:03Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
Published on: December 1, 2023